Target intelligence / Profile preview

Natural Killer Group 2, member D (NKG2D)

Target
NKG2D
Molecular classification
Receptor, C-type lectin-like receptor
01

Overview

NKG2D (Natural Killer Group 2, member D) is an activating receptor expressed on NK cells and subsets of T cells. It recognizes stress-induced ligands on target cells and triggers immune responses, including cytotoxicity and cytokine secretion, playing a crucial role in tumor surveillance and antiviral defense. It signals through DAP10 (humans and mice) and DAP12 (mice only) adaptor proteins.

Other names
KLRK1Killer cell lectin-like receptor K1
02

Mechanism of action

Agonist-induced activation of NKG2D leads to downstream signaling via DAP10 and/or DAP12 adaptor proteins, resulting in target cell lysis and cytokine production.

03

Biological functions

Immune responseCytotoxicityCytokine secretionCo-stimulationTumor surveillanceAntiviral defense
04

Disease associations

CancerInfectionAutoimmunity
05

Safety considerations

Potential for autoimmunity due to broad expression on immune cells.Off-target effects of agonists.

Beyond the preview

Go deeper on Natural Killer Group 2, member D (NKG2D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Killer Group 2, member D (NKG2D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call